A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCC

Summary

This is a phase I, open-label, single-arm study conducted to evaluate the efficacy, safety and PK of CGC738 in the treatment of advanced clear cell renal cell carcinoma (ccRCC).

Timeline

Start

2025-05-25

Primary completion

2026-08-01

Completion

2026-12-31

Drugs

Indications